Wioletta Makuch

3.8k total citations
71 papers, 3.2k citations indexed

About

Wioletta Makuch is a scholar working on Physiology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Wioletta Makuch has authored 71 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Physiology, 37 papers in Cellular and Molecular Neuroscience and 22 papers in Pharmacology. Recurrent topics in Wioletta Makuch's work include Pain Mechanisms and Treatments (67 papers), Neuropeptides and Animal Physiology (28 papers) and Pharmacological Effects of Natural Compounds (22 papers). Wioletta Makuch is often cited by papers focused on Pain Mechanisms and Treatments (67 papers), Neuropeptides and Animal Physiology (28 papers) and Pharmacological Effects of Natural Compounds (22 papers). Wioletta Makuch collaborates with scholars based in Poland, Italy and Hungary. Wioletta Makuch's co-authors include Joanna Mika, Barbara Przewłocka, Ewelina Rojewska, Anna Piotrowska, Maria Osikowicz, Agnieszka M. Jurga, Katarzyna Popiołek-Barczyk, Klaudia Kwiatkowski, Magdalena Żychowska and Ilona Obara and has published in prestigious journals such as PLoS ONE, Pain and International Journal of Molecular Sciences.

In The Last Decade

Wioletta Makuch

67 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wioletta Makuch Poland 37 2.2k 1.4k 666 560 509 71 3.2k
Ewelina Rojewska Poland 34 2.0k 0.9× 1.1k 0.8× 481 0.7× 585 1.0× 516 1.0× 57 2.8k
Fabien Marchand France 26 2.6k 1.2× 1.7k 1.2× 758 1.1× 483 0.9× 476 0.9× 52 4.3k
Yasuhiko Kawasaki United States 16 2.7k 1.2× 1.6k 1.1× 720 1.1× 387 0.7× 433 0.9× 22 3.7k
Anna K. Clark United Kingdom 26 2.5k 1.1× 1.5k 1.1× 726 1.1× 466 0.8× 519 1.0× 29 3.9k
Flobert Tanga United States 12 2.3k 1.0× 1.4k 1.0× 517 0.8× 326 0.6× 476 0.9× 13 3.1k
Shiroh Kishioka Japan 32 1.8k 0.8× 1.4k 1.0× 909 1.4× 238 0.4× 301 0.6× 123 3.3k
Marc R. Suter Switzerland 19 1.9k 0.9× 1.1k 0.8× 506 0.8× 335 0.6× 344 0.7× 49 2.6k
Sarah M. Sweitzer United States 25 1.9k 0.8× 1.1k 0.8× 464 0.7× 317 0.6× 374 0.7× 60 2.5k
Raghavendra Vasudeva United States 12 1.7k 0.8× 1.1k 0.7× 391 0.6× 215 0.4× 357 0.7× 19 2.4k
Yuan‐Xiang Tao United States 43 3.4k 1.5× 2.2k 1.5× 2.1k 3.1× 460 0.8× 304 0.6× 154 5.2k

Countries citing papers authored by Wioletta Makuch

Since Specialization
Citations

This map shows the geographic impact of Wioletta Makuch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wioletta Makuch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wioletta Makuch more than expected).

Fields of papers citing papers by Wioletta Makuch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wioletta Makuch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wioletta Makuch. The network helps show where Wioletta Makuch may publish in the future.

Co-authorship network of co-authors of Wioletta Makuch

This figure shows the co-authorship network connecting the top 25 collaborators of Wioletta Makuch. A scholar is included among the top collaborators of Wioletta Makuch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wioletta Makuch. Wioletta Makuch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pawlik, Katarzyna, Katarzyna Ciapała, A Ciechanowska, Wioletta Makuch, & Joanna Mika. (2025). Pharmacological modulation of neutrophils, in contrast to that of macrophages/microglia, is sex independent and delays the development of morphine tolerance in a mouse model of neuropathic pain. Biomedicine & Pharmacotherapy. 187. 118149–118149.
2.
Ciapała, Katarzyna, Katarzyna Pawlik, A Ciechanowska, Wioletta Makuch, & Joanna Mika. (2025). Promising effects of astaxanthin on pain-related behaviors and morphine tolerance in a mouse model of neuropathic pain: Possible involvement of Nrf2 and the NMDA receptor subunit NR2B. Neurotherapeutics. 22(6). e00765–e00765.
3.
Piotrowska, Anna, et al.. (2024). A New Application for Cenicriviroc, a Dual CCR2/CCR5 Antagonist, in the Treatment of Painful Diabetic Neuropathy in a Mouse Model. International Journal of Molecular Sciences. 25(13). 7410–7410. 5 indexed citations
4.
Kwiatkowski, Klaudia, Katarzyna Pawlik, Katarzyna Ciapała, et al.. (2020). Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Peripheral Neuropathy. Frontiers in Immunology. 11. 615327–615327. 25 indexed citations
5.
Piotrowska, Anna, Wioletta Makuch, Joanna Mika, et al.. (2020). Novel hybrid compounds, opioid agonist+melanocortin 4 receptor antagonist, as efficient analgesics in mouse chronic constriction injury model of neuropathic pain. Neuropharmacology. 178. 108232–108232. 13 indexed citations
6.
Pawlik, Krzysztof, et al.. (2019). The European Histamine Research Society48th Annual Meeting, May 15–18th, 2019 Kraków, Poland. Inflammation Research. 68(S1). 1–49. 1 indexed citations
7.
Bugno, Ryszard, Urszula Skupio, Wojciech Solecki, et al.. (2019). Functional characterization of a novel opioid, PZM21, and its effects on the behavioural responses to morphine. British Journal of Pharmacology. 176(23). 4434–4445. 30 indexed citations
8.
Piotrowska, Anna, Ewelina Rojewska, Katarzyna Pawlik, et al.. (2018). Pharmacological blockade of CXCR3 by (±)-NBI-74330 reduces neuropathic pain and enhances opioid effectiveness - Evidence from in vivo and in vitro studies. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(10). 3418–3437. 35 indexed citations
9.
Piotrowska, Anna, Ewelina Rojewska, Katarzyna Pawlik, et al.. (2018). Dataset of (±)-NBI-74330 (CXCR3 antagonist) influence on chemokines under neuropathic pain. Data in Brief. 21. 1145–1150. 4 indexed citations
10.
Kwiatkowski, Klaudia, Anna Piotrowska, Ewelina Rojewska, Wioletta Makuch, & Joanna Mika. (2017). The RS504393 Influences the Level of Nociceptive Factors and Enhances Opioid Analgesic Potency in Neuropathic Rats. Journal of Neuroimmune Pharmacology. 12(3). 402–419. 49 indexed citations
11.
Guillemyn, Karel, et al.. (2017). Bifunctional opioid/nociceptin hybrid KGNOP1 effectively attenuates pain-related behaviour in a rat model of neuropathy. European Journal of Pharmaceutical Sciences. 104. 221–229. 10 indexed citations
12.
Jurga, Agnieszka M., Anna Piotrowska, Wioletta Makuch, Barbara Przewłocka, & Joanna Mika. (2017). Blockade of P2X4 Receptors Inhibits Neuropathic Pain-Related Behavior by Preventing MMP-9 Activation and, Consequently, Pronociceptive Interleukin Release in a Rat Model. Frontiers in Pharmacology. 8. 48–48. 62 indexed citations
13.
Piłat, Dominika, Anna Piotrowska, Ewelina Rojewska, et al.. (2016). Blockade of IL-18 signaling diminished neuropathic pain and enhanced the efficacy of morphine and buprenorphine. Molecular and Cellular Neuroscience. 71. 114–124. 61 indexed citations
14.
Żychowska, Magdalena, Ewelina Rojewska, Wioletta Makuch, et al.. (2016). Participation of pro- and anti-nociceptive interleukins in botulinum toxin A-induced analgesia in a rat model of neuropathic pain. European Journal of Pharmacology. 791. 377–388. 61 indexed citations
15.
Mika, Joanna, Katarzyna Popiołek-Barczyk, Ewelina Rojewska, et al.. (2014). Delta-Opioid Receptor Analgesia Is Independent of Microglial Activation in a Rat Model of Neuropathic Pain. PLoS ONE. 9(8). e104420–e104420. 70 indexed citations
16.
Popiołek-Barczyk, Katarzyna, Ewelina Rojewska, Agnieszka M. Jurga, et al.. (2014). Minocycline Enhances the Effectiveness of Nociceptin/Orphanin FQ during Neuropathic Pain. BioMed Research International. 2014. 1–12. 29 indexed citations
17.
Makuch, Wioletta, Joanna Mika, Ewelina Rojewska, Magdalena Żychowska, & Barbara Przewłocka. (2013). Effects of selective and non-selective inhibitors of nitric oxide synthase on morphine- and endomorphin-1-induced analgesia in acute and neuropathic pain in rats. Neuropharmacology. 75. 445–457. 76 indexed citations
18.
Mika, Joanna, Magdalena Żychowska, Wioletta Makuch, Ewelina Rojewska, & Barbara Przewłocka. (2013). Neuronal and immunological basis of action of antidepressants in chronic pain – clinical and experimental studies. Pharmacological Reports. 65(6). 1611–1621. 79 indexed citations
19.
Mika, Joanna, Ewelina Rojewska, Wioletta Makuch, & Barbara Przewłocka. (2009). Minocycline reduces the injury-induced expression of prodynorphin and pronociceptin in the dorsal root ganglion in a rat model of neuropathic pain. Neuroscience. 165(4). 1420–1428. 94 indexed citations
20.
Parkitna, Jan Rodriguez, Ilona Obara, Agnieszka Wawrzczak‐Bargieła, et al.. (2006). Effects of Glycogen Synthase Kinase 3β and Cyclin-Dependent Kinase 5 Inhibitors on Morphine-Induced Analgesia and Tolerance in Rats. Journal of Pharmacology and Experimental Therapeutics. 319(2). 832–839. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026